Literature DB >> 17187863

Age-related macular degeneration is associated with incident myocardial infarction among elderly Americans.

Yinkang Duan1, Jingping Mo, Ronald Klein, Ingrid U Scott, Hung-Mo Lin, Joanne Caulfield, Manju Patel, Duanping Liao.   

Abstract

OBJECTIVE: To investigate whether age-related macular degeneration (AMD) is associated with the development of myocardial infarction (MI) among elderly Americans.
DESIGN: Population-based cross-sectional and cohort study. PARTICIPANTS: Five percent random sample of 2000 to 2003 Medicare enrollees.
METHODS: The cross-sectional study included the first 2-year (2000 and 2001) enrollees who were aged > or =65 years (n = 1,519,086). The cohort study included only baseline MI-free enrollees (n = 1445677). MAIN OUTCOME MEASURES: Chronic conditions (AMD and type, history of MI, hypertension, and diabetes) were defined based on any occurrence of relevant International Classification of Diseases 9 codes in relevant diagnosis fields of the baseline Medicare claim files. A total of 56611 incident MI cases were identified from the follow-up data (2002 and 2003).
RESULTS: Baseline mean age was 76 years, with 60% women and 88% whites. The prevalence of neovascular AMD was 2.2% (2.3% in women vs. 1.7% in men and 2.3% in whites vs. 1.2% in blacks; P<0.01 for both gender and race differences). The prevalence of nonneovascular AMD was 8.8% (9.9% in women vs. 7.3% in men and 9.5% in whites vs. 4.3% in blacks; P<0.01 for both gender and race differences). Baseline age-, gender-, and race-adjusted prevalences of hypertension, diabetes, and history of MI were 75%, 33%, and 5.00%, respectively, in the neovascular AMD group. In contrast, they were 73%, 27%, and 4.68% in the nonneovascular AMD group, and 65%, 25%, and 4.54% in the non-AMD group (P<0.01 for comparing the prevalence in neovascular and nonneovascular AMD vs. non-AMD groups). Prospectively, baseline age-, gender-, race-, hypertension-, and diabetes-adjusted 2-year incident odds ratios and 95% confidence intervals of MI associated with AMD are 1.19 (1.16-1.22) for all persons with AMD, 1.26 (1.20-1.33) for neovascular AMD, and 1.18 (1.14-1.21) for nonneovascular AMD.
CONCLUSIONS: AMD is associated with older age, female gender, being white, and having a history of MI, hypertension, and diabetes. Furthermore, presence of AMD, especially neovascular AMD, is prospectively associated with a higher risk of incident MI. These findings, if confirmed by other studies that control for smoking and other lifestyle covariables, suggest the possibility of shared common antecedents between MI and AMD.

Entities:  

Mesh:

Year:  2006        PMID: 17187863     DOI: 10.1016/j.ophtha.2006.07.045

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  42 in total

1.  [Age-related macular degeneration and risk of stroke].

Authors:  V Biousse; M-G Bousser; A Gaudric
Journal:  J Fr Ophtalmol       Date:  2008-01       Impact factor: 0.818

2.  Choriocapillaris dropout in early age-related macular degeneration.

Authors:  Gerard A Lutty; D Scott McLeod; Imran A Bhutto; Malia M Edwards; Johanna M Seddon
Journal:  Exp Eye Res       Date:  2020-01-24       Impact factor: 3.467

3.  In vivo bioluminescence imaging of hyperglycemia exacerbating stem cells on choroidal neovascularization in mice.

Authors:  Xiang Gao; Yu Wang; Hui-Yuan Hou; Yang Lyu; Hai-Yan Wang; Li-Bo Yao; Jian Zhang; Feng Cao; Yu-Sheng Wang
Journal:  Int J Ophthalmol       Date:  2016-04-18       Impact factor: 1.779

4.  Coronary Artery Disease and Reticular Macular Disease, a Subphenotype of Early Age-Related Macular Degeneration.

Authors:  Rachel M Cymerman; Adam H Skolnick; William J Cole; Camellia Nabati; Christine A Curcio; R Theodore Smith
Journal:  Curr Eye Res       Date:  2016-05-09       Impact factor: 2.424

Review 5.  Anti-VEGF therapies and blood pressure: more than meets the eye.

Authors:  Frank Enseleit; Stephan Michels; Frank Ruschitzka
Journal:  Curr Hypertens Rep       Date:  2010-02       Impact factor: 5.369

6.  SAVE-AMD: Safety of VEGF Inhibitors in Age-Related Macular Degeneration.

Authors:  Frank Enseleit; Stephan Michels; Isabella Sudano; Marc Stahel; Sandrine Zweifel; Oliver Schlager; Matthias Becker; Stephan Winnik; Matthias Nägele; Andreas J Flammer; Michel Neidhart; Nicole Graf; Christian M Matter; Burkhardt Seifert; Thomas F Lüscher; Frank Ruschitzka
Journal:  Ophthalmologica       Date:  2017-09-02       Impact factor: 3.250

7.  Prevalence of intermediate-stage age-related macular degeneration in patients with acquired immunodeficiency syndrome.

Authors:  Douglas A Jabs; Mark L Van Natta; Efe Sezgin; Jeong Won Pak; Ronald Danis
Journal:  Am J Ophthalmol       Date:  2015-03-11       Impact factor: 5.258

8.  Introducing Anti-Vascular Endothelial Growth Factor Therapies for AMD Did Not Raise Risk of Myocardial Infarction, Stroke, and Death.

Authors:  Arseniy P Yashkin; Paul Hahn; Frank A Sloan
Journal:  Ophthalmology       Date:  2016-08-11       Impact factor: 12.079

9.  Air Pollution and the microvasculature: a cross-sectional assessment of in vivo retinal images in the population-based multi-ethnic study of atherosclerosis (MESA).

Authors:  Sara D Adar; Ronald Klein; Barbara E K Klein; Adam A Szpiro; Mary Frances Cotch; Tien Y Wong; Marie S O'Neill; Sandi Shrager; R Graham Barr; David S Siscovick; Martha L Daviglus; Paul D Sampson; Joel D Kaufman
Journal:  PLoS Med       Date:  2010-11-30       Impact factor: 11.069

10.  Relationship between RPE and choriocapillaris in age-related macular degeneration.

Authors:  D Scott McLeod; Rhonda Grebe; Imran Bhutto; Carol Merges; Takayuki Baba; Gerard A Lutty
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-04-08       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.